Melanoma Session 1

Oral Abstract Presenter(s)

• 

  Michael Carr, MD, MS

  Surgical Oncology Research Fellow
  Moffitt Cancer Center
  Tampa, Florida, United States
• 

  Norma Farrow, MD

  General Surgery Resident
  Duke University
• 

  Hidde Kroon, MD, PhD

  Gastro-intestinal and oncological surgeon
  Royal Adelaide Hospital
  Adelaide, South Australia, Australia
• 

  James Sun, MD

  Research Fellow
  Moffitt Cancer Center
  Tampa, Florida, United States
• 

  Winan van Houdt, MD, PhD

  Surgeon
  Netherlands Cancer Institute
  Amsterdam, Netherlands

Presentations:

• 7:15 AM – 7:30 AM

  Current Adjuvant Therapy Use in the Setting of Sentinel Node Positivity for Melanoma
  Norma E. Farrow, MD – Duke University
• 7:30 AM – 7:45 AM

  An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma
  Norma E. Farrow, MD – Duke University
• 7:45 AM – 8:00 AM

  Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: A Multi-Institutional Experience
  James Sun, MD – Moffitt Cancer Center
• 8:00 AM – 8:15 AM

  International Multi-Center Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients
  Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital; Michael J. Carr, MD, MS – Moffitt Cancer Center
• 8:15 AM – 8:30 AM

  International Comparison of Oncologic Outcomes after Isolated Limb Infusion (ILI) for Advanced Melanoma
  Michael J. Carr, MD, MS – Moffitt Cancer Center
• 8:30 AM – 8:45 AM

  Isolated Limb Perfusion as an Effective Treatment Modality for Locally Advanced Kaposi Sarcoma of the Extremities
  Winan van Houdt, MD, PhD – Netherlands Cancer Institute